HuGE Literature Finder
Records
1
-
3
[Clinical Predictive Factors associated with First Line EGFR-TKI Efficacy ?in Advanced NSCLC Patients with EGFR Mutations]. Zhongguo fei ai za zhi = Chinese journal of lung cancer 2019 Feb 22 (2): 99-104. Chen Minjiang, Xu Yan, Zhao Jing, Zhong Wei, Wang Mengzh |
A phase II open-label multicenter study of gefitinib in combination with irradiation followed by chemotherapy in patients with inoperable stage III non-small cell lung cancer. Oncotarget 2016 Oct . Levy Antonin, Bardet Etienne, Lacas Benjamin, Pignon Jean-Pierre, Adam Julien, Lacroix Ludovic, Artignan Xavier, Verrelle Pierre, Le Péchoux Céci |
Mutations in NSCLC and their link with lung cancer-associated thrombosis: a case-control study. Thrombosis research 2014 Jan 133 (1): 48-51. Corrales-Rodriguez Luis, Soulières Denis, Weng Xiaoduan, Tehfe Mustapha, Florescu Marie, Blais Norma |
- Page last reviewed:Oct 1, 2021
- Page last updated:May 25, 2022
- Content source: